Comparing Exertional Heat Illness Risk Factors Between Patients and Controls

May 19, 2023 updated by: Jo Corbett, University of Portsmouth

Comparison of Novel Putative Risk Factors for Exertional Heat Illness Between a Military Patient Cohort and Matched Control Cohort During Exercise Heat Stress

The arduous nature of military training and operations require personnel to encounter high heat load, e.g., during intense physical exertion, particularly in the heat. These conditions reduce operational effectiveness and expose personnel to a risk of incapacitation and death from exertional heat illness (EHI). The primary aim of this study is to compare putative 'chronic' EHI risk factors between a cohort who have suffered a history of EHI and a control cohort with no EHI history. The secondary aim is to examine the influence of these EHI risk factors on thermoregulation during a standard heat tolerance assessment.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Military training and operations present a risk of incapacitation and death from Exertional Heat Illness (EHI). However, widely accepted EHI risk factors are absent in almost half of all United Kingdom (UK) military EHI cases, indicating that a significant number of EHI cases in military personnel involve alternative risk factors. Risk factors for EHI can been classified along a spectrum ranging from acute (e.g. recent poor sleep) to chronic (e.g. low fitness), with the role of chronic risk factors supported by the observation that individuals who have suffered an EHI are at a substantially increased risk of subsequent EHI. The primary aim of this study is to compare putative 'chronic' EHI risk factors (e.g. composition of gastrointestinal (GI) microbiome, infection and inflammation, trait-like psychological factors) between a cohort who have suffered a history of EHI and a control cohort with no EHI history. The secondary aim is to examine the influence of these EHI risk factors on thermoregulation during a standard heat tolerance assessment.

Study Type

Observational

Enrollment (Actual)

95

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hampshire
      • Portsmouth, Hampshire, United Kingdom, PO1 2UP
        • University of Portsmouth

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Individuals who have experienced a recent exertional heat illness and matched controls with no previous history of exertional heat illness

Description

Inclusion Criteria:

Individuals with a history of EHI:

  • Previous EHI episode
  • Normal resting ECG
  • Male or female
  • 18 - 40 years

Control participants:

  • No previous history of EHI
  • Normal resting ECG
  • Male or female
  • 18 - 40 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Individuals with a history of EHI
Service personnel who have a history of EHI.
60-90 minutes exercise in hot (34 °C; 45% R.H.) conditions at 60%VO2max
Control participants without a history of EHI

Matched control participants with no history of EHI. They will be matched to the experimental group for parameters that are known to influence thermoregulatory responses to exercise heat-stress.

  1. Relative aerobic fitness (V̇O2max; ml∙kg-1∙min-1)
  2. Body mass (kg)
  3. Body surface area (m2)
  4. Age
  5. Sex
60-90 minutes exercise in hot (34 °C; 45% R.H.) conditions at 60%VO2max

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Core temperature
Time Frame: At 60 minutes (or test termination if earlier) of Heat Tolerance Assessment
Measured using a rectal thermistor.
At 60 minutes (or test termination if earlier) of Heat Tolerance Assessment
Core temperature
Time Frame: Rate of rise from 30 to 60 minutes (or test termination if earlier) of Heat Tolerance Assessment
Measured using a rectal thermistor.
Rate of rise from 30 to 60 minutes (or test termination if earlier) of Heat Tolerance Assessment
Diversity of gastrointestinal microbiota
Time Frame: Baseline
Measured in stool sample. Assessed by alpha diversity score.
Baseline
Diversity of gastrointestinal microbiota
Time Frame: Baseline
Measured in stool sample. Assessed by beta diversity score.
Baseline
Abundance of gastrointestinal microbiota
Time Frame: Baseline
Measured in stool sample. Assessed at level of phylum.
Baseline
Detection of sexually transmitted pathogens
Time Frame: Baseline
Assessed from urine sample. Measured using cobas CT/NG assays.
Baseline
Detection of respiratory pathogens
Time Frame: Baseline
Assessed from throat swab. Measured using Allplex assays.
Baseline
Detection of gastrointestinal pathogens
Time Frame: Baseline
Assessed from stool swab. Measured using Allplex.
Baseline
Circulating Interleukin 6
Time Frame: Baseline
Measured using ELISA
Baseline
Circulating Interleukin 6
Time Frame: Post Heat Tolerance Assessment (within 15 minutes of test end)
Measured using ELISA
Post Heat Tolerance Assessment (within 15 minutes of test end)
Circulating C-Reactive Protein
Time Frame: Baseline
Measured using ELISA
Baseline
Circulating C-Reactive Protein
Time Frame: Post Heat Tolerance Assessment (within 15 minutes of test end)
Measured using ELISA
Post Heat Tolerance Assessment (within 15 minutes of test end)
Circulating Claudin 3
Time Frame: Baseline
Measured using ELISA
Baseline
Circulating Claudin 3
Time Frame: Post Heat Tolerance Assessment (within 15 minutes of test end)
Measured using ELISA
Post Heat Tolerance Assessment (within 15 minutes of test end)
Circulating Zonulin
Time Frame: Baseline
Measured using ELISA
Baseline
Circulating lipopolysaccharide binding protein
Time Frame: Baseline
Measured using ELISA
Baseline
Circulating lipopolysaccharide binding protein
Time Frame: Post Heat Tolerance Assessment (within 15 minutes of test end)
Measured using ELISA
Post Heat Tolerance Assessment (within 15 minutes of test end)
Circulating intestinal fatty acid binding protein
Time Frame: Baseline
Measured using ELISA
Baseline
Circulating intestinal fatty acid binding protein
Time Frame: Post Heat Tolerance Assessment (within 15 minutes of test end)
Measured using ELISA
Post Heat Tolerance Assessment (within 15 minutes of test end)
Gastrointestinal illness symptomology questionnaire
Time Frame: Baseline
Visual analogue scale (0-10). Higher scores indicate worse symptomology
Baseline
Gastrointestinal illness symptomology questionnaire
Time Frame: Pre Heat Tolerance Assessment
Visual analogue scale (0-10). Higher scores indicate worse symptomology
Pre Heat Tolerance Assessment
Gastrointestinal illness symptomology questionnaire
Time Frame: Immediately post Heat Tolerance Assessment
Visual analogue scale (0-10). Higher scores indicate worse symptomology
Immediately post Heat Tolerance Assessment
Respiratory illness symptomology, measured by Jackson common cold questionnaire
Time Frame: Baseline
Higher scores indicate worse symptomology
Baseline
Sleep quality and quantity, measured by Pittsburgh Sleep Quality Index
Time Frame: Baseline -3 days
Higher scores indicate worse sleep
Baseline -3 days
Motivation, measured by Motivation scale
Time Frame: Baseline -3 days
Baseline -3 days
State-trait anxiety, measured by state-trait anxiety inventory form Y-2
Time Frame: Baseline -3 days
Baseline -3 days
Risk taking, measured by the risk-taking inventory
Time Frame: Baseline -3 days
Baseline -3 days
Resilience, measured by the Connor-Davidson resilience scale
Time Frame: Baseline -3 days
Baseline -3 days
Stress, measured by perceived stress scale
Time Frame: Baseline -3 days
Baseline -3 days
Mental readiness
Time Frame: Baseline
Visual analogue scale (0-100). Higher scores indicate a lower state of mental readiness.
Baseline
Stress
Time Frame: Baseline
Visual analogue scale (0-100). Higher scores indicate a greater state of stress.
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heat rate
Time Frame: At 5 minute intervals during the Heat Tolerance Assessment
At 5 minute intervals during the Heat Tolerance Assessment
Thermal comfort
Time Frame: At 15 minute intervals during Heat Tolerance Assessment
Modified 9 point Gagge scale. Higher scores indicate worse comfort.
At 15 minute intervals during Heat Tolerance Assessment
Thermal sensation
Time Frame: At 15 minute intervals during Heat Tolerance Assessment
Modified 9 point Gagge scale. Higher scores indicate hotter sensation
At 15 minute intervals during Heat Tolerance Assessment
Rating of Perceived Exertion
Time Frame: At 15 minute intervals during Heat Tolerance Assessment
6-20 Borg scale. Higher scores indicate higher perceived exertion
At 15 minute intervals during Heat Tolerance Assessment
Skin Temperature
Time Frame: During Heat Tolerance Assessment
Weighted mean skin temperature
During Heat Tolerance Assessment
Sweat rate
Time Frame: During Heat Tolerance Assessment
Determined from change in nude body mass during the heat tolerance assessment
During Heat Tolerance Assessment

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body mass
Time Frame: Baseline
Baseline
Relative maximal aerobic fitness
Time Frame: Baseline
Highest value measured in ml.kg-1.min-1 during a treadmill graded exercise test.
Baseline
Urine osmolality
Time Frame: Baseline
Measured using freezing point depression
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2022

Primary Completion (Actual)

March 6, 2023

Study Completion (Actual)

March 6, 2023

Study Registration Dates

First Submitted

February 3, 2022

First Submitted That Met QC Criteria

March 21, 2022

First Posted (Actual)

March 31, 2022

Study Record Updates

Last Update Posted (Actual)

May 22, 2023

Last Update Submitted That Met QC Criteria

May 19, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 209321

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exertional Heat Illness

Clinical Trials on Heat Tolerance Assessment

Subscribe